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Introduction 1 
 2 
Dizziness is an extremely common symptom. One survey showed that over 20% of 18 to 64 3 
year olds registered at four GP surgeries in London had experienced dizziness within the 4 
preceding month.1 Patients with vertigo can experience violent spinning episodes for hours 5 
at a time.2 Vertigo can have many causes, and although a wide range of clinical tests are 6 
available, they are often undertaken in the absence of a dizzy attack.3 Furthermore, patient 7 
reporting of vertigo is subjective and imprecise.4 Therefore, dizziness can be challenging to 8 
diagnose and it would be beneficial to diagnose patients quickly and accurately, reducing 9 
the burden on health services.  10 
 11 
Observation of eye movements is informative when assessing the dizzy patient. Vertigo is 12 
usually accompanied by nystagmus, and different patterns of nystagmus can help provide a 13 
diagnostic insight into the underlying cause of a patient’s symptoms.5,6 For example, 14 
nystagmus beating in the horizontal plane is often characteristic of problems in the inner 15 
ear, whereas nystagmus in the vertical plane can be suggestive of central causes.7 We have 16 
developed the Continuous Ambulatory Vestibular Assessment (CAVA®) device to provide 17 
valuable long-term eye movement data (Figure 1), and computer algorithms for analysing 18 
the data collected by the device in the community. As with conventional 19 
electronystagmography, the CAVA® device records horizontal and vertical eye-movements 20 
but does not capture torsional eye-movement data. This system provides an objective 21 
record of the presence, duration and frequency of nystagmus, gathered over a period of 22 
thirty days. 23 
 24 
The CAVA® system has proven capable of detecting induced nystagmus and nystagmus in 25 
patients suffering from a variety of vestibular conditions.8–11 The long-term data captured 26 
can provide an objective record of the presence of nystagmus, which patients are unlikely to 27 
report accurately by themselves. We have previously shown that nystagmus during a 28 
Ménière’s attack has unique temporal characteristics, which could be used to assist in 29 
diagnosing the condition.10 Other conditions, such as Benign Paroxysmal Positional Vertigo 30 
(BPPV), are distinct in that they are motion-provoked, and nystagmus is short in duration. 31 
BPPV from nystagmus typically beats torsionally and vertical upwards, although only the 32 
vertical component can be detected by the CAVA® system. The information provided by the 33 
CAVA® system is expected to supplement and complement a full neurotological history and 34 
examination, assisting the clinician to make or confirm a diagnosis.11 35 
 36 
The large quantity of data captured by the device makes manual inspection of the data 37 
impractical. To overcome this issue, we have previously developed and evaluated 38 
algorithms to automatically detect different patterns of nystagmus,9 for subsequent review  39 
and interpretation by a clinician. Eye movement data can be difficult to interpret from 40 
manual inspection of separate vertical and horizontal channels, especially if the eye 41 
movements are complex or rare.12 Additionally, some clinicians may have more experience 42 
examining the eyes than looking at signal traces. Patients themselves would better 43 
understand their own symptoms from a video representation of their eye-movements 44 
rather than complex signal traces. In this article, we describe an approach to reproduce 45 
animated eye movements from the long-term, horizontal and vertical electrooculography 46 
data provided by the CAVA® device. The recreated movements imitate the appearance of 47 
the eyes, excluding torsional eye-movements, and largely allowing clinicians to review 48 
episodes of vertigo as if they were present with the patient during an attack. We 49 
demonstrate that the results obtained are visually comparable to actual video footage of 50 
the patient’s eyes. The data analysed exemplifies the challenges associated with 51 
interpreting eye-movement signals and highlights the benefits of reanimating them in 2D. 52 
 53 
Materials and Methods 54 
 55 
We are currently undertaking a clinical investigation into the capabilities of our device to 56 
detect pathological nystagmus from patients with a range of vestibular conditions. This 57 
work is part of a larger portfolio of work funded by the UK Medical Research Council to 58 
develop a full medical system for diagnosing dizziness.  During the “training” phase of this 59 
investigation, we have collected data from patients with vertigo which will be used to 60 
develop our computer algorithms for detecting nystagmus. The work presented here was 61 
undertaken using data from patients enrolled onto this training phase. This clinical 62 
investigation was reviewed and approved by the London-Dulwich Research Ethics 63 
Committee (IRAS Number: 261099) 64 
 65 
Patients enrolled into our clinical trial wore the CAVA® device for thirty consecutive days. 66 
They attended three separate follow-up appointments during the trial. The first, on day five, 67 
was to check that the patient was getting on well with their device and to check for adverse 68 
skin reactions. The second, on day fourteen, was to change the device’s battery. After day 69 
thirty-one, patients returned their device and completed a questionnaire. In this article, we 70 
present data from two of the trial participants. Patient One was a 53-year-old lady with a 71 
fifteen-year history of left-sided unilateral Ménière’s disease. Patient Two was a 56-year-old 72 
lady with a three-year history of positional vertigo. For Patient One, we reanimated her 73 
nystagmus eye movements from a Ménière’s attack she experienced during her thirty-day 74 
trial, in her own home. For Patient Two, we reanimated her nystagmus during a Dix-Hallpike 75 
test, undertaken in a clinical setting at her day fourteen follow-up appointment. We also 76 
recorded concurrent video footage of Patient Two’s eyes during this test. The video was 77 
recorded using a Canon 200D Digital SLR camera, at 1920 x 1080 pixels, at 60 frames per 78 
second. 79 
 80 
The CAVA® device (Figure 1) records the corneo-retinal potential produced by the eyes, 81 
which is a proxy for eye movement. Horizontal eye movement is captured by way of two 82 
electrodes placed at the outer canthi of the eyes, and vertical eye movement by two 83 
electrodes placed above and below the left eye. A fifth electrode beneath the right ear 84 
provides a reference voltage. This technology is similar to electrooculography and 85 
electronystagmography, which have been used routinely for decades,13 and as such the 86 
CAVA® device does not capture torsional eye-movements. Also, as with 87 
electronystagmography, the CAVA® device would require frequent recalibration in order to 88 
relate the signals recorded to precise eye-movements in degrees. As we are presently only 89 
interested in identifying nystagmus signals and comparing them qualitatively, here we 90 
present eye-movements using native device units. The device also contains an 91 
accelerometer which records three-axis head movements. Each channel of eye movement is 92 
sampled at 42.67 Hz and each acceleration channel is sampled at 20 Hz. 93 
 94 
We developed software to simultaneously visualise the two-channel eye-movement data 95 
provided by the CAVA® device, the video data (for Patient Two), and a 2D reconstructed 96 
animation of the patients’ eye movements. This software, which was created using 97 
Mathwork’s MATLAB, generates a video file showing the three modalities playing in real-98 
time: vertical and horizontal eye-movement traces, an animated reconstruction of the eyes 99 
and concurrent video footage of the patient’s eyes. Prior to visualisation and reconstruction, 100 
each eye movement channel was pre-processed to remove signal drift and high frequency 101 
noise, such as interference from mains electricity, both common issues when working with 102 
electrooculography data.14 To achieve this, a bandpass filter was applied to the data (Figure 103 
2). The filter used a high-pass threshold of 0.20 Hz and a low-pass threshold of 6 Hz. 104 
 105 
Animated eye-movements were reconstructed by plotting the filtered horizontal and 106 
vertical eye-movement channels onto two separate 2D plots, designed to imitate the 107 
appearance of the pupils of the eyes. Although the CAVA® device does not record left and 108 
right eye movements independently, both eyes are shown in order to generate a more 109 
realistic and interpretable animation. The axes limits of the reconstructed plots were 110 
selected such that all of the patient’s eye-movement data would be visible within the plots. 111 
The video data was temporally aligned with the eye-movement data using activation of the 112 
CAVA® device’s event marker as a reference point. As the device and video data were 113 
captured at different sample rates, care was taken to maintain alignment of these data 114 




Patient One returned their device after thirty days and reported an acute Ménière’s attack 119 
consisting of an episode of rotary vertigo lasting approximately three hours. Analysis of the 120 
eye-movement traces from the CAVA® device showed clear evidence of sporadic, left- and 121 
right-beating jerk nystagmus throughout the period indicated by the patient. The full details 122 
of this attack have been reported previously.10 A thirty-second extract of the device data 123 
was processed by our software to generate a new video showing the horizontal and vertical 124 
eye-movement traces alongside a 2D-reconstruction of the patient’s eye movements (Figure 125 
3 and Supplemental Movie 1). The reconstruction confirmed the presence of right-beating, 126 
jerk nystagmus during the reported vertigo attack. 127 
 128 
Patient Two returned after thirty days, reporting several short episodes of motion-provoked 129 
vertigo during the trial. At Patient Two’s second follow-up visit, three right-sided Dix-130 
Hallpike manoeuvres were performed. Visual observation of the patient’s eyes during these 131 
tests showed nystagmus beating torsionally with the upper pole of the eye to the right-hand 132 
side, and vertically upward.  The nystagmus lasted for less than thirty seconds. These 133 
observations confirmed right posterior canal, BPPV canalithiasis. Consistent with the 134 
response “fatigue” that has been reported previously, the first manoeuvre yielded the 135 
strongest nystagmus response.15 To compare the patient’s actual eye-movements with 136 
those recreated from the device data, we recorded video of the patient’s eyes whilst they 137 
underwent the manoeuvre. The video and device data were processed by our software to 138 
generate a new video showing these modalities alongside a 2D-reconstruction of the 139 
patient’s eye movements (Figure 3 and Supplemental Movie 2). Observation of the CAVA® 140 
device’s horizontal and vertical eye movement data showed evidence of up-beating 141 
nystagmus in the vertical channel (Figure 3a-b). 142 
 143 
The 2D animated reconstruction of Patient Two’s eye-movements revealed an obvious 144 
visual correlation between the reconstruction and the video footage (Figure 3c and 3d). At 145 
about 00:13:36, the patient can be seen to blink (Figure 3d), and this appears as a fast, 146 
upward eye excursion in both the eye movement traces (Figure 3a-b) and the 147 
reconstruction (Figure 3c). From the reconstruction, Patient Two’s eyes can also be seen to 148 
move in an arching motion towards the right-hand side of her face. This motion could not 149 
easily be identified from the eye-movement traces alone, but is clearly visible both in the 150 
reconstruction and in the video footage. As purely torsional eye-movements cannot be 151 
captured using electrode-based electronystagmography, no torsional movements are visible 152 
in the reconstruction, despite being visible in the video footage. The device’s accelerometer 153 
data confirmed that the patient underwent a right-sided Dix-Hallpike test. Both the 154 
reconstruction and the video showed clear evidence of nystagmus starting approximately 155 
seven seconds after the patient was placed into a supine position, which lasted for 156 
approximately nine seconds. Up-beating nystagmus is visible in the vertical channel and the 157 
trace has an oscillatory appearance. After the nystagmus had subsided, the patients’ eyes 158 




The results presented here have provided proof-of-concept that signals captured by the 163 
CAVA® device largely reflect the actual eye-movements displayed by patients. We were able 164 
to use reconstructed animated eye movements to observe the up-beating component of 165 
nystagmus present in a patient undergoing a Dix-Hallpike manoeuvre and also the jerk 166 
nystagmus experienced by a patient experiencing an attack of Ménière’s disease, in her own 167 
home. In the absence of a video recording of a patient’s eyes or without being physically 168 
present with a patient during a vertigo attack, an animated 2D reconstruction would enable 169 
clinicians to retrospectively evaluate the presence and characteristics of nystagmus, and 170 
would aid discussions with the patient regarding their vertigo. Clinicians may favour the 171 
animated 2D reconstruction because they are familiar with observing physical eye 172 
movements, or as highlighted here, because of the complexity of the signal under 173 
interrogation. 174 
 175 
This study is the first to recreate eye-movements from the long-term data provided by the 176 
CAVA® device for the purpose of assessing dizziness. Due to the emergence of 177 
videonystagmography technology, electrooculography has decreased in popularity for 178 
recording nystagmus in clinical settings.16 Interpreting eye movements from 179 
electrooculography (EOG) data remains an active area of research in the field of Human-180 
Computer-Interaction (HCI). Applications of EOG in HCI tend to focus on the automatic 181 
detection of specific eye-movement gestures to facilitate some kind of computer-based 182 
activity, often to assist people with quadriplegia to interact with a computer.17 183 
 184 
There is a clear similarity between the data captured by the CAVA® device and the actual 185 
eye-movements experienced by patients. This relationship is sufficient to allow a qualitative 186 
comparison between nystagmus from different patients and between nystagmus resulting 187 
from different conditions. There are several issues which make discriminating the 188 
characteristics of nystagmus more challenging. As with ENG, the relationship between eye-189 
movements and native device units is only linear up to ± 30 degrees.18 This is an 190 
unavoidable limitation of electrode-based systems, so care should be taken when visualising 191 
large excursions of the eye. It is also not possible to record pure torsional eye-movements 192 
using electrode-based systems. Such eye-movements are common with BPPV, although they 193 
are usually accompanied by a vertical component. 194 
 195 
A further challenge shared with conventional electrode-based electronystagmography is 196 
that frequent device calibration is usually required to determine precise eye-movements in 197 
degrees. This is due to the variability of the Corneo-Retinal Potential (CRP), which is the 198 
bioelectrical signal used by both systems as a proxy for eye-movement. Calibration can be 199 
performed by the subject performing a calibration task, such as predefined eye movements 200 
(e.g. moving the eyes by ± 30 degrees), in order to calculate the number of native device 201 
units per degree of eye movement. Alternatively, an average calibration value could be 202 
used, with a known margin of error. We did not perform these steps here as it is possible to 203 
determine the presence of nystagmus, its duration and beat-direction without prior 204 
calibration. 205 
 206 
BPPV is the most common cause of vertigo, and by far the most common cause of motion-207 
provoked vertigo. Thus, nystagmus correlated with head-movements, as confirmed by the 208 
CAVA® device’s accelerometer data, would provide a likely first indication of BPPV. Further 209 
supporting data is provided by the fact that the onset of nystagmus is delayed for BPPV but 210 
not for vertigo with central causes, and the nystagmus produced as a consequence of BPPV 211 
is fatigable whereas for central causes it is not. Posterior canalithiasis is the most common 212 
form of BPPV, accounting for around 90% of cases. Therefore, in the majority of cases, the 213 
side the person lies on would indicate the affected side and the affected canal. Confirmation 214 
of motion-provoked vertigo fulfilling these criteria could be used in conjunction with a full 215 
neurotological history and examination to supplement a clinician’s diagnosis. 216 
 217 
We have shown here that eye blinks are reconstructed as short duration, vertical eye 218 
movements, which could be misinterpreted as genuine, vertical eye-movements. Some 219 
vertical movement can occur during blinking (Bell’s phenomenon), but this is unlikely to fully 220 
account for the signals captured.19 In light of this, it could be useful to develop ways to 221 
automatically detect blinks in the data, to alert the clinician of their presence. 222 
 223 
The method of reconstructing eye movements presented here provides an alternative 224 
representation of the data captured by the CAVA® device, allowing easier interpretation of 225 
the patient’s eye movements and confirming the presence of nystagmus to a clinician. Our 226 
ultimate goal is to further develop this system from one that detects nystagmus to one that 227 
can provide useful insights regarding the nature of the nystagmus detected. If deployed into 228 
routine medical care, we expect that the CAVA® system would be provided to patients in 229 
secondary care settings, most likely to provide an objective confirmation of vertigo and to 230 
aid the discrimination of possible vestibular causes. The system could provide insight into 231 
conditions with a degree of overlap, such as Ménière’s disease and vestibular migraine, or 232 
for patients with coexistent conditions, such a dual diagnosis of BPPV and Ménière’s 233 
disease. A combination of a full neurotologic history, examination and the nystagmus 234 
recorded over thirty-days would then guide a clinician towards the most likely diagnosis and 235 
treatment options. For example, hearing loss combined with prolonged episodes of 236 
direction-changing vertigo might suggest Ménière’s disease. Prolonged nystagmus in the 237 
vertical plane might suggest a central cause. BPPV might be suggested by short durations of 238 
up-beating nystagmus, with a latency following a provocative head-movement, and this 239 
would be confirmed by a Dix-Hallpike test. As we work towards this goal, we next intend to 240 
undertake a clinical trial to determine whether the nystagmus signals captured by the 241 
CAVA® device are sufficient by themselves to differentiate some of the most common inner-242 
ear causes of vertigo. 243 
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Figure 4319 
Figure 1: The appearance of the CAVA® device when worn on the head. The device includes 320 
a reusable logging module and two, single-use electrode mounts. Five ECG electrodes are 321 
placed at specific sites on the face to record the corneo retinal potential produced by the 322 
eyes. A button on the logging unit allows the patient to activate the device’s event marker, 323 
which causes the device to log the date and time of the button press. The button can also be 324 
used to initiate a status check of the device, the results of which are confirmed visually by 325 
the device’s status LED.  The status checking feature provides feedback regarding battery 326 
level, the connection of the device’s electrodes, and confirmation of event marker 327 
activation. 328 
 329 
Figure 2: Panels (a) and (b) display a 28-second, horizontal eye-movement trace captured by 330 
the CAVA® device. The waveforms show an extract of nystagmus produced by a patient with 331 
Ménière’s disease. In panel (a), the signal has not been filtered, and shows evidence of 332 
signal drift and high frequency noise. In (b), the signal has been filtered using a bandpass 333 
filter, with a passband of 0.20 Hz to 6 Hz. The filtered signal retains the characteristic 334 
sawtooth nystagmus waveform shape whilst discarding the signal drift and the higher 335 
frequency noise. 336 
 337 
Figure 3: The initial frame of a video showing the eye-movements of a patient experiencing 338 
an acute attack of Ménière’s disease. The signal shown is an extract from an attack which 339 
lasted for approximately three hours, in total. (a) and (b) show the horizontal and vertical 340 
eye movement traces as captured by the CAVA® device. The black line marks the current 341 
timestamp. (c) Shows the animated reconstruction of the eye movements in 2D. 342 
 343 
Figure 4: The initial frame of a video showing the eye-movements of a patient undergoing a 344 
Dix-Hallpike manourvre. (a) and (b) show the horizontal and vertical eye movement traces 345 
as captured by the CAVA® device. The black line marks the current timestamp, and event 346 
marker activations are shown as orange lines. (c) Shows an animated reconstruction of the 347 
patient’s eye movements in 2D. The video in (d) shows the clinician activating the device’s 348 
event marker, performing the Dix-Hallpike manourvre on the patient, followed by a closeup 349 
of the patient’s eyes. The first event marker activation allowed the eye-movement channels 350 
to be aligned temporally with the video of the patient undergoing to the procedure. The 351 
second activation was at the first sign of nystagmus, which coincided with the patient 352 
reporting the onset of vertigo, and the final event mark was deployed after the nystagmus 353 
had ceased.  The green line in (b) is the point at which the video in (d) is rotated by 180 354 
degrees, so that they are presented in the same orientation. 355 
